Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
-17.1%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$5.69B
AUM Growth
-$1.36B
(-19%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-2.35%
Top 10 Holdings %
Top 10 Hldgs %
17.58%
Holding
1,139
New
165
Increased
376
Reduced
380
Closed
175
Top Buys
| 1 |
Starbucks
SBUX
|
+$60M |
| 2 |
CELG
Celgene Corp
CELG
|
+$24M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$22.6M |
| 4 |
TJX Companies
TJX
|
+$20.5M |
| 5 |
Synopsys
SNPS
|
+$18.9M |
Top Sells
| 1 |
Dell
DELL
|
+$45.2M |
| 2 |
Rockwell Automation
ROK
|
+$25.3M |
| 3 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$22.9M |
| 4 |
Accenture
ACN
|
+$21.4M |
| 5 |
General Motors
GM
|
+$19.6M |
Sector Composition
| 1 | Technology | 19.85% |
| 2 | Financials | 17.71% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Healthcare | 11.49% |
| 5 | Industrials | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HALL
801
DELISTED
Hallmark Financial Services, Inc.
HALL
| $325K | 0.01% |
3,043
-216
| -7% | -$23.1K |
|
802
QuinStreet
QNST
$933M
| $321K | 0.01% |
19,799
-5,755
| -23% | -$93.3K |
|
803
US Bancorp
USB
$76.8B
| $319K | 0.01% |
6,990
-1,110
| -14% | -$50.7K |
|
804
Upbound Group
UPBD
$1.47B
| $317K | 0.01% |
+19,580
| New | +$317K |
|
|
SCTL
805
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $317K | 0.01% |
49,800
+9,143
| +22% | +$58.2K |
|
806
Adverum Biotechnologies
ADVM
$72.8M
| $313K | 0.01% |
9,933
+3,904
| +65% | +$123K |
|
|
WIRE
807
DELISTED
Encore Wire Corp
WIRE
| $311K | 0.01% |
6,200
| – | – |
|
|
ACC
808
DELISTED
American Campus Communities, Inc.
ACC
| $306K | 0.01% |
+7,400
| New | +$306K |
|
809
Adeia
ADEA
$1.68B
| $303K | 0.01% |
62,344
-26,486
| -30% | -$129K |
|
810
Greenlight Captial
GLRE
$431M
| $303K | 0.01% |
+35,173
| New | +$303K |
|
|
MODN
811
DELISTED
MODEL N, INC.
MODN
| $299K | 0.01% |
22,590
| – | – |
|
|
TTPH
812
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $299K | 0.01% |
13,233
+5,148
| +64% | +$116K |
|
813
Aon
AON
$79B
| $298K | 0.01% |
+2,050
| New | +$298K |
|
814
Agilysys
AGYS
$3.03B
| $297K | 0.01% |
20,698
-7,263
| -26% | -$104K |
|
815
Markel Group
MKL
$24.4B
| $292K | 0.01% |
281
-323
| -53% | -$336K |
|
816
Cidara Therapeutics
CDTX
$1.6B
| $286K | 0.01% |
6,084
+145
| +2% | +$6.82K |
|
|
ISEE
817
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $285K | 0.01% |
237,547
-1,200
| -0.5% | -$1.44K |
|
|
CALA
818
DELISTED
Calithera Biosciences, Inc
CALA
| $283K | 0.01% |
3,523
-1,043
| -23% | -$83.8K |
|
819
Enpro
NPO
$4.52B
| $282K | 0.01% |
4,692
| – | – |
|
820
Marchex
MCHX
$88.4M
| $280K | ﹤0.01% |
105,757
-31,589
| -23% | -$83.6K |
|
|
INSY
821
DELISTED
Insys Therapeutics, Inc.
INSY
| $279K | ﹤0.01% |
+79,700
| New | +$279K |
|
822
Pultegroup
PHM
$27B
| $276K | ﹤0.01% |
10,620
| – | – |
|
|
NTGN
823
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $276K | ﹤0.01% |
+54,954
| New | +$276K |
|
824
Karyopharm Therapeutics
KPTI
$54.9M
| $275K | ﹤0.01% |
1,953
+6
| +0.3% | +$845 |
|
|
BMTC
825
DELISTED
Bryn Mawr Bank Corp
BMTC
| $275K | ﹤0.01% |
8,007
-700
| -8% | -$24K |
|